Gildan (GIL) (FFIV) (UBSI) (EW) (EXAS) (FDO) Upgraded

Gildan Activewear (NYSE: GIL), F5 Networks (NASDAQ: FFIV), United Bankshares, Inc. (NASDAQ: UBSI), Edwards Lifesciences (NYSE: EW), EXACT Sciences Co. (NASDAQ: EXAS) and Family Dollar Stores, Inc. (NYSE: FDO) upgraded by analysts.

F5 Networks (FFIV) was upgraded by Goldman Sachs (NYSE:GS) from a “Sell” rating to a “Neutral” rating. They have a price target of $94.00 on the company.

United Bankshares, Inc. (UBSI) was upgraded by UBS AG (NYSE:UBS) from a “Neutral” rating to a “Buy” rating.

Edwards Lifesciences (EW) was upgraded by Rodman & Renshaw from an “Underperform” rating to a “Market Perform” rating. They have a price target of $66.00 on the company.

Gildan Activewear (GIL) was upgraded by FBR Capital from an “Underperform” rating to a “Market Perform” rating. They have a price target of $27.00 on the company.

EXACT Sciences Co. (EXAS) was upgraded by Rodman & Renshaw from a “Market Perform” rating to an “Outperform” rating. They have a price target of $12.00 on the company, up from $7.00.

Family Dollar Stores, Inc. (FDO) was upgraded by Goldman Sachs (NYSE:GS) from a “Neutral” rating to a “Buy” rating. They have a price target of $60.00 on the company.

Diodes (DIOD) (EXAS) (ADI) (AGP) (ALL) (AMR) Downgraded

Diodes (NASDAQ: DIOD), EXACT Sciences Co. (NASDAQ: EXAS), Analog Devices, Inc. (NYSE: ADI), AMERIGROUP Co. (NYSE: AGP), Allstate (NYSE: ALL) and AMR Corp. (NYSE: AMR) downgraded by analysts.

Diodes (DIOD) was downgraded by Sterne Agee from a “Buy” rating to a “Neutral” rating.

EXACT Sciences Co. (EXAS) was downgraded by Rodman & Renshaw from an “Outperform” rating to a “Market Perform” rating.

Analog Devices, Inc. (ADI) was downgraded by Sterne Agee from a “Buy” rating to a “Neutral” rating.

AMERIGROUP Co. (AGP) was downgraded by Bank of America (NYSE:BAC) from a “Buy” rating to an “Underperform” rating. They have a price target of $46.00 on the company.

Allstate (ALL) was downgraded by Goldman Sachs (NYSE:GS) from a “Neutral” rating to a “Sell” rating.

AMR Co. (AMR) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) from an “Overweight” rating to a “Neutral” rating.